New study investigates immune protein VISTA in MS patients

NCT ID NCT06957145

Recruiting now Knowledge-focused Sponsor: Koç University Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Jun 15, 2026 · Updated 31 times

Summary

This study aims to understand if a protein called VISTA, which helps control the immune system, is different in people with multiple sclerosis (MS) compared to healthy individuals. Researchers will collect blood samples from 60 participants (MS patients and healthy controls) and measure VISTA levels in certain immune cells. The goal is to see if VISTA could be used as a biomarker to track MS or help develop new treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS (MS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Bakirkoy Prof. Dr. Mazhar Osman Training and Research Hospital for Psychiatric, Neurologic and Neurosurgical Diseases, University of Health Sciences, Istanbul, Turkey
RECRUITING

Istanbul, Turkey (Türkiye)

Contact Phone: •••-•••-•••• Email: •••••@•••••
Koc University
RECRUITING

Istanbul, Istanbul, Turkey (Türkiye)

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

MULTIPLE SCLEROSIS (MS)